Genetic Conversations:

Inspiring Confidence & Fostering Partnerships For Therapy Development

Wednesday May 8th , 2024

National Aquarium, Baltimore
7.00pm - 9.30pm EDT

Reserve your place

Join us at the Baltimore Aquarium for an evening of meaningful conversation and an engaging evening reception, as experts explore the potential of genetic insights and partnerships that contribute to positive change in therapy development.

  • Discover ways to ensure reproducibility, product comparability and assay standardization
  • Understand benefits and barriers of analytical test for lot release specifications with different technologies
  • Learn about areas of collaboration that can accelerate go-to market timelines
Reserve your place

Enjoy the Evening
Wednesday May 8th, 2024

Arrival & Networking

7-7.30pm

Panel Discussion

7.30-8.30pm

Reception & Exhibits

8.30-9.30pm

Reserve your place

Join The Experts

ENJOY EXCLUSIVE INSIGHTS FROM OUR EXPERT INDUSTRY SPEAKERS.

Chandler Walker

Product Manager, Digital PCR Instruments

Thermo Fisher Scientific

View Bio

Lingzhi Zhao, PHD

VP and Head of Discovery Biology and Gene Therapy

NeuShen

View Bio

Dwight Baker

Chief Innovation Officer

Resilience

View Bio

Kinnari Patel, PharmD, MBA

President, Head of R&D and Chief Operating Officer

Rocket Pharma

View Bio

Hari Acharya, PHD

Director, Process Development

Capsida Biotherapeutics

View Bio

SHARDHA MILLINGTON

Consultant

Citeline Moderator

View Bio

Panel Discussion 

Genetic Conversations: Inspiring Confidence & Fostering Partnerships For Therapy Development

Cell and Gene therapies have had an immense impact in the life sciences industry thus far, with continued innovation promising more real-world success in patients with high unmet needs. Genetic analyses are essential in the development of novel life-changing therapies for patients from the discovery phase to commercialization. As the novel therapeutics grow more complex and regulatory compliance increases it is important to optimize the drug development processes and workflows to help accelerate time to market. Data risks and compliance remain critical pain points for biopharma companies, especially smaller organizations that lack the resources and funding to support lengthy clinical trials. Therefore, it is imperative that decision-makers are aware of solutions that streamline and expedite cell and gene therapy development.

Discussion points will include:

  • The current gene therapy landscape and associated compliance challenges
  • How to streamline genetic analysis workflows to bring therapies to market efficiently
  • Key regulatory considerations for advanced therapies, including specifics on mRNA and cell and gene therapies (CGTs)
  • Best practices for incorporating compliant technology into genetic analysis workflows
  • How to build trust and confidence in data through strategic partnerships
Reserve your place

Getting There

National Aquarium

501 E Pratt St,
Baltimore, MD 21202

Register now

By ticking this box, you agree to receive emails from Citeline, and carefully selected partners
I would like Thermo Fisher Scientific Group (including its affiliates) to add me to a list to receive information about events, products, services, and promotions which Thermo Fisher believes may be of interest to me via the following channels: Email and Phone. I can withdraw my consent and unsubscribe at any time by emailing reply@thermofisher.com. I acknowledge Thermo Fisher Scientific (including its affiliates) and Citeline will process my Personal Information. This is subject to Thermo Fisher Scientific Inc.’s privacy policy and Citeline’s privacy policy which includes information about my rights.